Dr Richard Kones
Editor-in-Chief: Richard Kones
Richard Kones MD began as a mathematically inclined chemical engineer, and then attended NYU School of Medicine in a special pilot program. Inspired by a mentor in the Physiology department, he conducted independent research studying aldosterone with a novel technique, and became a full member of the New York Academy of Sciences while still in medical school. He completed training in New York and continued a NIH Fellowship in cardiology at Tulane University School of Medicine, also working at the Charity Hospital and Veterans Administration Hospital in New Orleans. He returned to New York Medical College to continue researching actions of inotropic agents, myocardial function, preservation of ischemic myocardium, and cardiogenic shock, eventually relocating in Texas. An avid supporter of applications of biochemistry and physiology, he continued teaching and publishing, emphasizing translational research. In addition to presentations, lectures, has mentored medical students and house staff at several medical schools and affiliated hospitals. His interests gradually turned to the role pathological signaling plays in the pathogenesis of atherothrombosis, especially the interaction of inflammatory mechanisms, endothelial dysfunction, mitochondrial involvement in disease, lipid metabolism, metabolic syndrome and related evidence-based interventions to improve clinical outcomes. Fundamental mechanisms and molecular and cellular cardiology have been central to his work, as well as the practical aspects of how simple lifestyle and dietary changes may be powerful tools to minimize risk factors.
During the course of his academic career he has received several scholarships, awards, and grants. His work includes publications in peer-reviewed medical journals, books, presentations, and lectures. He serves on a number of committees in various medical organizations, peer reviews for a variety of medical journals, and volunteers for the mentoring programs in the American Society for Clinical Pharmacology and Therapeutics and American Heart Association. Over the years Dr. Kones’ bio has appeared in a number of editions of Who’s Who and other biographical registries. Two years ago he was appointed one of the founding editors of Medpedia online, a collaborative educational project among several medical schools which has enjoyed considerable success. Dr. Kones is a Board Member of the Committees on Cardiovascular Disease, Internal Medicine, and Nutrition of the Medpedia project.
He is a Fellow of the Royal Society of Medicine and the Royal Society of Health, a Fellow of the New York Cardiological Society, now merged with the New York Chapter of the American College of Cardiology, a Founding Fellow of the American Geriatrics Society, a member of the Heart Rhythm Society, the European Society of Cardiology, Council for Cardiology Practice, European Heart Rhythm Association and Heart Failure Association. Dr. Kones is an emeritus member of the American Physiological Society, a member of The Physiological Society and The Nutrition Society in London, as well as the International Union of the Physiological Sciences. He is also a member of several Councils in the American Heart Association, a Fellow of the American College of Pharmacology, and was recently elected to the American Society for Clinical Pharmacology and Therapeutics. His other affiliations include the Society for Critical Care Medicine, European Atherosclerosis Society, International Atherosclerosis Society, American Society for Hypertension, National Lipid Association, American Association of Cardiovascular and Pulmonary Rehabilitation, American Society for Preventive Cardiology, Society of Atherosclerosis Imaging and Prevention, International Society for Heart Research, Heart Failure Society of America, American Diabetes Association, Endocrine Society, American Thoracic Society, and Inflammation Research Association. He has also been a long-standing active member of the French Society of Cardiology and other notable scientific organizations and working groups.